Joseph Raffaele: Can Improving Mitochondrial Quality in Immune Cells Alter Immune Aging Markers?
Joseph Raffaele, Physician-Scientist in Longevity Medicine, CEO of PhysioAge LLC, shared a post on LinkedInย about a recent article by Dominic Denk et al, published in Nature Aging:
”Mitochondria shape immune function over decades.
A recent human trial asked whether we could change this fate.
If we improve mitochondrial quality inside immune cells, can we alter immune aging markers in people?
As immune cells age, mitochondrial dysfunction accumulates.
Damaged mitochondria persist due to impaired mitophagy (damaged mitochondria cleanup).
Energy production declines, reactive oxygen species increase, and immune cells drift toward exhaustion and chronic inflammatory signaling.
In this study, 50 healthy middle-aged adults received ๐,๐๐๐ ๐ฆ๐ /๐๐๐ฒ ๐จ๐ ๐ฎ๐ซ๐จ๐ฅ๐ข๐ญ๐ก๐ข๐ง ๐ ๐๐จ๐ซ ๐๐จ๐ฎ๐ซ ๐ฐ๐๐๐ค๐ฌ, a compound shown to induce mitophagy and improve mitochondrial quality control.
Primary endpoints focused on phenotypic and metabolic remodeling of peripheral immune cells, rather than nonspecific clinical outcomes.
Participants receiving urolithin A showed:
- An expansion of naรฏve-like CD8 T cells
- Improved immune cell metabolic flexibility
- Increased mitochondrial biogenesis in key immune populations
Importantly, inflammatory cytokines and immune function were evaluated alongside cellular metabolism, allowing investigators to directly link mitochondrial quality with immune behavior rather than treating them as separate phenomena.
What makes this study important is the template it provides.
Aging biology advances when trials target a known mechanism, measure the right cell populations, and use human-relevant endpoints. This is the kind of evidence that moves geroscience from theory toward clinical practice.”
Title: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
Authors: Dominic Denk, Anurag Singh, Herbert G. Kasler, Davide DโAmico, Julia Rey, Lucรญa Alcober-Boquet, Johanna M. Gorol, Christoph Steup, Ritesh Tiwari, Ryan Kwok, Rafael J. Argรผello, Julie Faitg, Kathrin Sprinzl, Stefan Zeuzem, Valentina Nekljudova, Sibylle Loibl, Eric Verdin, Chris Rinsch, Florian R. Greten
Read the Full Article on Nature Aging
Stay updated withย Hemostasis Today.
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India
-
Oct 16, 2026, 09:59Tareq Abadl: A Simple Guide to Blood Collection Tubes
-
Oct 16, 2026, 09:50Mona Alfaraj: Distinguishing HCL from SMZL in Bone Marrow
-
Oct 16, 2026, 09:44New International Consensus on Covert Brain Infarction – International Journal of Stroke